BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33493138)

  • 1. Expression and prognostic analyses of SCAMPs in pancreatic adenocarcinoma.
    Mao F; Duan H; Allamyradov A; Xin Z; Du Y; Wang X; Xu P; Li Z; Qian J; Yao J
    Aging (Albany NY); 2021 Jan; 13(3):4096-4114. PubMed ID: 33493138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
    Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
    Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
    Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
    Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrate analysis of the promote function of Cell division cycle-associated protein family to pancreatic adenocarcinoma.
    Xing C; Wang Z; Zhu Y; Zhang C; Liu M; Hu X; Chen W; Du Y
    Int J Med Sci; 2021; 18(3):672-684. PubMed ID: 33437202
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
    Front Immunol; 2022; 13():805311. PubMed ID: 35154122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High
    Lv S; Zhang G; Xie L; Yan Z; Wang Q; Li Y; Zhang L; Han Y; Li H; Du Y; Yang Y; Guo X
    Biomed Res Int; 2020; 2020():2585862. PubMed ID: 32185195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of CENPL mRNA potentially regulated by miR-340-3p predicts the prognosis of pancreatic cancer patients.
    Cui Z; Du L; Wang J; Li Z; Xu J; Ou S; Li D; Li S; Hu H; Chen G; Wu Z
    BMC Cancer; 2022 Dec; 22(1):1354. PubMed ID: 36572856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LACTB mRNA expression is increased in pancreatic adenocarcinoma and high expression indicates a poor prognosis.
    Xie J; Peng Y; Chen X; Li Q; Jian B; Wen Z; Liu S
    PLoS One; 2021; 16(1):e0245908. PubMed ID: 33507917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic impact of FZDs in pancreatic adenocarcinoma.
    Li Y; Liu Z; Zhang Y
    BMC Gastroenterol; 2021 Feb; 21(1):79. PubMed ID: 33618667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SCAMP2/5 as diagnostic and prognostic markers for acute myeloid leukemia.
    Yue C; Xie S; Zhong J; Zhao H; Lin Z; Zhang L; Xu B; Luo Y
    Sci Rep; 2021 Aug; 11(1):17012. PubMed ID: 34426610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of E2F Transcription Factor Expression in Pancreatic Adenocarcinoma.
    Luo L; Zhang G; Wu T; Wu G
    Med Sci Monit; 2021 Nov; 27():e933443. PubMed ID: 34799547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of leukemia inhibitory factor and its receptor in pancreatic adenocarcinoma.
    Wang D; Liu K; Yang Y; Wang T; Rao Q; Guo W; Zhang Z
    Future Oncol; 2020 Jan; 16(3):4461-4473. PubMed ID: 31854204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of zinc transporter ZIP4, ZIP11, ZnT1, and ZnT6 predicts poor prognosis in pancreatic cancer.
    Zhu B; Huo R; Zhi Q; Zhan M; Chen X; Hua ZC
    J Trace Elem Med Biol; 2021 May; 65():126734. PubMed ID: 33631610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpressed CA12 has prognostic value in pancreatic cancer and promotes tumor cell apoptosis via NF-κB signaling.
    Du Y; Xin Z; Liu T; Xu P; Mao F; Yao J
    J Cancer Res Clin Oncol; 2021 May; 147(5):1557-1564. PubMed ID: 33387040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-132 Plays an Independent Prognostic Role in Pancreatic Ductal Adenocarcinoma and Acts as a Tumor Suppressor.
    Chen Y; Zhu H; Wang Y; Song Y; Zhang P; Wang Z; Gao J; Li Z; Du Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033818824314. PubMed ID: 30803373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma.
    Xu Q; Zheng J; Su Z; Chen B; Gu S
    BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver-Metastasis-Related Genes are Potential Biomarkers for Predicting the Clinical Outcomes of Patients with Pancreatic Adenocarcinoma.
    Dong Y; Tian J; Yan B; Lv K; Li J; Fu D
    Pathol Oncol Res; 2021; 27():1609822. PubMed ID: 34290570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel genes associated with a poor prognosis in pancreatic ductal adenocarcinoma via a bioinformatics analysis.
    Zhou J; Hui X; Mao Y; Fan L
    Biosci Rep; 2019 Aug; 39(8):. PubMed ID: 31311829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of long non-coding RNA expression profiles in pancreatic ductal adenocarcinoma.
    Fu XL; Liu DJ; Yan TT; Yang JY; Yang MW; Li J; Huo YM; Liu W; Zhang JF; Hong J; Hua R; Chen HY; Sun YW
    Sci Rep; 2016 Sep; 6():33535. PubMed ID: 27628540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.